The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons

被引:205
作者
Perrin-Vidoz, L
Sinilnikova, OM
Stoppa-Lyonnet, D
Lenoir, GM
Mazoyer, S [1 ]
机构
[1] Fac Med Rockefeller, UMR 5641, Genet Lab, F-69373 Lyon 08, France
[2] Int Agcy Res Canc, F-69372 Lyon, France
[3] Hop Edouard Herriot, Genet Lab, F-69437 Lyon 03, France
[4] Inst Curie, Serv Genet Oncol, F-75248 Paris 05, France
关键词
D O I
10.1093/hmg/11.23.2805
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germline mutations in the BRCA1 gene are scattered over the 22 coding exons and most of them generate premature termination codons (PTCs). A mechanism called nonsense-mediated mRNA decay (NMD) is known to specifically degrade transcripts with PTCs; however, steady-state amounts of mutant BRCA1 mRNAs have very rarely been measured. Although growing evidence implicates downstream exon-exon junctions (EEJs) as critical determinants for discrimination between normal stop codons and PTCs, requirements concerning the minimal and maximal distance between PTCs and downstream EEJs are still debated. We assessed the relative amount of transcripts encoded by BRCA1 alleles harbouring 30 different truncating mutations in lymphoblastoid cell lines established from carriers from breast/ovarian cancer families. We found that NMD is triggered by 80% of PTC+ alleles and results in a 1.5- to 5-fold reduction in mRNA abundance. All truncating mutations located in the 3.4 kb long central exon are subject to NMD, irrespective of their distance to the downstream EEJ (305 to 3395 nt). PTCs not leading to NMD are either located in the last exon or very close to the translation initiation codon. We hypothesize that reinitiation could explain why transcripts carrying early PTCs escape NMD. This is the first study challenging the NMD rules, which have been established through the study of minigenes, by analysing a large series of mutant endogenous alleles.
引用
收藏
页码:2805 / 2814
页数:10
相关论文
共 65 条
[41]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[42]   Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast ovarian cancer families [J].
Montagna, M ;
Santacatterina, M ;
Torri, A ;
Menin, C ;
Zullato, D ;
Chieco-Bianchi, L ;
D'Andrea, E .
ONCOGENE, 1999, 18 (28) :4160-4165
[43]  
Montagna M, 1996, CANCER RES, V56, P5466
[44]   Splicing and 3′ end formation in the definition of nonsense-mediated decay-competent human β-globin mRNPs [J].
Neu-Yilik, G ;
Gehring, N ;
Thermann, R ;
Frede, U ;
Hentze, MW ;
Kulozik, AE .
EMBO JOURNAL, 2001, 20 (03) :532-540
[45]   MESSENGER-RNA DESTABILIZATION TRIGGERED BY PREMATURE TRANSLATIONAL TERMINATION DEPENDS ON AT LEAST 3 CIS-ACTING SEQUENCE ELEMENTS AND ONE TRANS-ACTING FACTOR [J].
PELTZ, SW ;
BROWN, AH ;
JACOBSON, A .
GENES & DEVELOPMENT, 1993, 7 (09) :1737-1754
[46]   An Alu-mediated 6-kb duplication in the BRCA1 gene:: A new founder mutation? [J].
Puget, N ;
Sinilnikova, OM ;
Stoppa-Lyonnet, D ;
Audoynaud, C ;
Pages, S ;
Lynch, HT ;
Goldgar, D ;
Lenoir, GM ;
Mazoyer, S .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) :300-302
[47]  
Puget N, 1997, CANCER RES, V57, P828
[48]  
Puget N, 1999, CANCER RES, V59, P455
[49]   Nonsense-mediated decay of human HEXA mRNA [J].
Rajavel, KS ;
Neufeld, EF .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) :5512-5519
[50]  
Rodningen OK, 1999, HUM MUTAT, V13, P186, DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO